» Articles » PMID: 8176462

Refining Interpretation of MIBG Scans in Children

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 1994 May 1
PMID 8176462
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: In pediatrics, the distribution of radioiodinated metaiodobenzylguanidine (MIBG) has been studied primarily in neuroblastoma. However, normal patterns in children show a number of particularities and pitfalls related to the context of pediatric oncology which must be identified.

Methods: We report on 28 equivocal scans in 24 children. In all cases, two experienced observers judged the scans to be equivocal and the definite interpretations were confirmed by follow-up.

Results: Difficulties in interpreting the scans were observed at the level of the thorax (15 patients), the abdomen (5 patients), the head (4 patients) or elsewhere (4 patients). The final interpretation of the scans was attributed to an unusual physiological pattern linked to age (9 patients), tumoral context (17 patients) or artifacts (2 patients).

Conclusions: A number of important physiological areas of uptake in soft tissues can lead to false-positive interpretations of normal scans, such as the physiological upper thoracic uptake which has never been previously described. Numerous technical and physiological possibilities exist and those pitfalls must be ruled out. A precise knowledge of these technical difficulties and physiological variants can reduce the number of equivocal MIBG scans.

Citing Articles

Does the Incremental Value of I-Metaiodobenzylguanidine SPECT/CT over Planar Imaging Justify the Increase in Radiation Exposure?.

Ben-Sellem D, Ben-Rejeb N Nucl Med Mol Imaging. 2021; 55(4):173-180.

PMID: 34422127 PMC: 8322371. DOI: 10.1007/s13139-021-00707-5.


Guidelines on nuclear medicine imaging in neuroblastoma.

Bar-Sever Z, Biassoni L, Shulkin B, Kong G, Hofman M, Lopci E Eur J Nucl Med Mol Imaging. 2018; 45(11):2009-2024.

PMID: 29938300 DOI: 10.1007/s00259-018-4070-8.


Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.

Xia J, Zhang H, Hu Q, Liu S, Zhang L, Zhang A J Huazhong Univ Sci Technolog Med Sci. 2017; 37(5):649-660.

PMID: 29058276 DOI: 10.1007/s11596-017-1785-x.


123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat G, Adam J, Caron H, Kremer L, Hooft L Cochrane Database Syst Rev. 2015; (9):CD009263.

PMID: 26417712 PMC: 4621955. DOI: 10.1002/14651858.CD009263.pub2.


Clinical experience with (18)F-fluorodeoxyglucose positron emission tomography and (123)I-metaiodobenzylguanine scintigraphy in pediatric neuroblastoma: complementary roles in follow-up of patients.

Gil T, Lee D, Lee J, Yoo E, Ryu K Korean J Pediatr. 2014; 57(6):278-86.

PMID: 25076973 PMC: 4115069. DOI: 10.3345/kjp.2014.57.6.278.